Basic Information
Basic information for XIST-221-16aa-2
Peptide Name XIST-221-16aa-2
Genome Position chrX:73824782-73824829[-]
Species Human
Peptide Sequence MLPVTFRLTVLCLGQS
Peptide Length 16
Unique No (XIST-204-16aa-3,XIST-206-16aa,XIST-211-16aa,XIST-212-16aa,XIST-214-16aa,XIST-215-16aa-2,XIST-216-16aa,XIST-217-16aa,XIST-218-16aa-1,XIST-219-16aa-2,XIST-222-16aa-1,XIST-223-16aa-1,XIST-224-16aa-2,XIST-225-16aa-3,XIST-226-16aa,XIST-230-16aa-2)
Grand Average of Hydropathicity 1.1625
Relative Molecular Mass 2048.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000229807;XIST
Transcript ID/Name ENST00000649757;XIST-221
Transcript Length 5272
Coding Ability 0.463
DNA Sequence Corresponding to Peptide ATGTTGCCGGTTACCTTTAGATTGACAGTATTATGCCTGGGCCAGTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :